Molecular mechanisms of tumor vascularization

Critical Reviews in Oncology/Hematology

Volumn 54, Issue 1, 2005, Pages 53-61

  Auguste, Patrick ^a,b,c   Lemiere, Sylvie ^a   Larrieu Lahargue, Fréderic ^a   Bikfalvi, Andreas ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Angiogenesis research; Tumor therapy; Tumor vascularization

Indexed keywords

ANGIOSTATIN; BEVACIZUMAB; ENDOSTATIN; FIBROBLAST GROWTH FACTOR; THROMBOSPONDIN; VASCULOTROPIN;

ANGIOGENESIS; CLINICAL TRIAL; COLORECTAL CARCINOMA; HUMAN; LYMPHANGIOGENESIS; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NONHUMAN; REVIEW; TUMOR CLASSIFICATION; TUMOR VASCULARIZATION;

EID: 15244350721     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2004.11.006     Document Type: Review

References (85)

1. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
2. J. Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
3. M.J. Hendrix, E.A. Seftor, A.R. Hess, and R.E. Seftor Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma Nat Rev Cancer 3 2003 411 421
4. M. Streit, and M. Detmar Angiogenesis, lymphangiogenesis, and melanoma metastasis Oncogene 22 2003 3172 3179
5. T. Makinen, and K. Alitalo Molecular mechanisms of lymphangiogenesis Cold Spring Harb Symp Quant Biol 67 2002 189 196
6. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389 395
7. N.W. Gale, and G.D. Yancopoulos Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development Genes Dev 13 1999 1055 1066
8. P.C. Maisonpierre, C. Suri, and P.F. Jones Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 1997 55 60
9. J. Plouet, J. Schilling, and D. Gospodarowicz Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells Embo J 8 1989 3801 3806
10. N. Ferrara, and W.J. Henzel Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells Biochem Biophys Res Commun 161 1989 851 858
11. D.T. Connolly, D.M. Heuvelman, and R. Nelson Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis J Clin Invest 84 1989 1470 1478
12. T.H. Vu, J.M. Shipley, and G. Bergers MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes Cell 93 1998 411 422
13. M.S. Pepper, N. Ferrara, L. Orci, and R. Montesano Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells Biochem Biophys Res Commun 181 1991 902 906
14. G. Bergers, R. Brekken, and G. McMahon Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat Cell Biol 2 2000 737 744
15. H. Gerhardt, M. Golding, and M. Fruttiger VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia J Cell Biol 161 2003 1163 1177
16. S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R.K. Jain, and D.M. McDonald Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors Am J Pathol 160 2002 985 1000
17. P. Lindahl, B.R. Johansson, P. Leveen, and C. Betsholtz Pericyte loss and microaneurysm formation in PDGF-B-deficient mice Science 277 1997 242 245
18. A. Abramsson, O. Berlin, H. Papayan, D. Paulin, M. Shani, and C. Betsholtz Analysis of mural cell recruitment to tumor vessels Circulation 105 2002 112 117
19. M.C. Dickson, J.S. Martin, F.M. Cousins, A.B. Kulkarni, S. Karlsson, and R.J. Akhurst Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice Development 121 1995 1845 1854
20. D.Y. Li, L.K. Sorensen, and B.S. Brooke Defective angiogenesis in mice lacking endoglin Science 284 1999 1534 1537
21. Y. Liu, R. Wada, and T. Yamashita Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation J Clin Invest 106 2000 951 961
22. M.S. Pepper, D. Belin, R. Montesano, L. Orci, and J.D. Vassalli Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro J Cell Biol 111 1990 743 755
23. P. Auguste, D.B. Gursel, and S. Lemiere Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms Cancer Res 61 2001 1717 1726
24. G. Seghezzi, S. Patel, and C.J. Ren Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis J Cell Biol 141 1998 1659 1673
25. C. Saucier, H. Khoury, and K.M. Lai The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis Proc Natl Acad Sci USA 2004
26. J.K. Wang, G. Gao, and M. Goldfarb Fibroblast growth factor receptors have different signaling and mitogenic potentials Mol Cell Biol 14 1994 181 188
27. H. Kubo, T. Fujiwara, and L. Jussila Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis Blood 96 2000 546 553
28. J.A. Nagy, E. Vasile, and D. Feng Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis J Exp Med 196 2002 1497 1506
29. W. Risau, H. Drexler, and V. Mironov Platelet-derived growth factor is angiogenic in vivo Growth Factors 7 1992 261 266
30. M. Hermanson, K. Funa, and M. Hartman Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops Cancer Res 52 1992 3213 3219
31. M. Wagner, T. Cao, and M.E. Lopez Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum Int J Cancer 68 1996 782 787
32. P.H. Burri, and V. Djonov Intussusceptive angiogenesis - the alternative to capillary sprouting Mol Aspects Med 23 2002 S1 S27
33. V.G. Djonov, H. Kurz, and P.H. Burri Optimality in the developing vascular system: branching remodeling by means of intussusception as an efficient adaptation mechanism Dev Dyn 224 2002 391 402
34. V. Djonov, A.C. Andres, and A. Ziemiecki Vascular remodelling during the normal and malignant life cycle of the mammary gland Microsc Res Tech 52 2001 182 189
35. S. Patan, L.L. Munn, and R.K. Jain Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis Microvasc Res 51 1996 260 272
36. S. Patan, S. Tanda, S. Roberge, R.C. Jones, R.K. Jain, and L.L. Munn Vascular morphogenesis and remodeling in a human tumor xenograft: blood vessel formation and growth after ovariectomy and tumor implantation Circ Res 89 2001 732 739
37. S. Patan, L.L. Munn, S. Tanda, S. Roberge, R.K. Jain, and R.C. Jones Vascular morphogenesis and remodeling in a model of tissue repair: blood vessel formation and growth in the ovarian pedicle after ovariectomy Circ Res 89 2001 723 731
38. V. Djonov, O. Baum, and P.H. Burri Vascular remodeling by intussusceptive angiogenesis Cell Tissue Res 314 2003 107 117
39. G. Thurston, C. Suri, and K. Smith Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 Science 286 1999 2511 2514
40. E. Crivellato, B. Nico, A. Vacca, V. Djonov, M. Presta, and D. Ribatti Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo Leukemia 18 2004 331 336
41. S. Rafii Circulating endothelial precursors: mystery, reality, and promise J Clin Invest 105 2000 17 19
42. M.A. Moore Putting the neo into neoangiogenesis J Clin Invest 109 2002 313 315
43. M. Reyes, A. Dudek, B. Jahagirdar, L. Koodie, P.H. Marker, and C.M. Verfaillie Origin of endothelial progenitors in human postnatal bone marrow J Clin Invest 109 2002 337 346
44. S.Y. Rabbany, B. Heissig, K. Hattori, and S. Rafii Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization Trends Mol Med 9 2003 109 117
45. S. Rafii, B. Heissig, and K. Hattori Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors Gene Ther 9 2002 631 641
46. D. Lyden, K. Hattori, and S. Dias Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nat Med 7 2001 1194 1201
47. A.M. Davidoff, C.Y. Ng, and P. Brown Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice Clin Cancer Res 7 2001 2870 2879
48. S. Marchetti, C. Gimond, and K. Iljin Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo J Cell Sci 115 2002 2075 2085
49. J. Holash, P.C. Maisonpierre, and D. Compton Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 284 1999 1994 1998
50. W.P. Leenders, B. Kusters, and R.M. de Waal Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis Endothelium 9 2002 83 87
51. D. Zagzag, R. Amirnovin, and M.A. Greco Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis Lab Invest 80 2000 837 849
52. S. Miraux, R. Pineau, and M. Pluderi Inhibition of FGF receptor activity in glioma implanted into the mouse brain using the tetracyclin-regulated expression system Angiogenesis 7 2004 105 113
53. B. Kusters, W.P. Leenders, and P. Wesseling Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis Cancer Res 62 2002 341 345
54. J.L. Rubenstein, J. Kim, and T. Ozawa Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption Neoplasia 2 2000 306 314
55. P. Vajkoczy, M. Farhadi, and A. Gaumann Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2 J Clin Invest 109 2002 777 785
56. P. Kunkel, U. Ulbricht, and P. Bohlen Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2 Cancer Res 61 2001 6624 6628
57. E.S. Kim, A. Serur, and J. Huang Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma Proc Natl Acad Sci USA 99 2002 11399 11404
58. J.U. Prause, and O.A. Jensen Scanning electron microscopy of frozen-cracked, dry-cracked and enzyme-digested tissue of human malignant choroidal melanomas Albrecht Von Graefes Arch Klin Exp Ophthalmol 212 1980 217 225
59. Y.S. Chang, E. di Tomaso, D.M. McDonald, R. Jones, R.K. Jain, and L.L. Munn Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood Proc Natl Acad Sci USA 97 2000 14608 14613
60. J. Folkman Can mosaic tumor vessels facilitate molecular diagnosis of cancer? Proc Natl Acad Sci USA 98 2001 398 400
61. A.J. Maniotis, R. Folberg, and A. Hess Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry Am J Pathol 155 1999 739 752
62. M. Bittner, P. Meltzer, and Y. Chen Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature 406 2000 536 540
63. M.J. Hendrix, E.A. Seftor, A.R. Hess, and R.E. Seftor Molecular plasticity of human melanoma cells Oncogene 22 2003 3070 3075
64. R.E. Seftor, E.A. Seftor, and N. Koshikawa Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma Cancer Res 61 2001 6322 6327
65. A.R. Hess, E.A. Seftor, and L.M. Gardner Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2) Cancer Res 61 2001 3250 3255
66. M.J. Hendrix, E.A. Seftor, and P.S. Meltzer Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry Proc Natl Acad Sci USA 98 2001 8018 8023
67. E. Passalidou, M. Trivella, and N. Singh Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas Br J Cancer 86 2002 244 249
68. N. Sharma, R.E. Seftor, and E.A. Seftor Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry Prostate 50 2002 189 201
69. AK. Sood, EA. Seftor, and MS. Fletcher Molecular determinants of ovarian cancer plasticity Am J Pathol 158 2001 1279 1288
70. K. Shirakawa, S. Furuhata, and I. Watanabe Induction of vasculogenesis in breast cancer models Br J Cancer 87 2002 1454 1461
71. K. Shirakawa, H. Wakasugi, and Y. Heike Vasculogenic mimicry and pseudo-comedo formation in breast cancer Int J Cancer 99 2002 821 828
72. K. Shirakawa, H. Kobayashi, and Y. Heike Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft Cancer Res 62 2002 560 566
73. D.M. McDonald, L. Munn, and R.K. Jain Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 156 2000 383 388
74. W. Ruf, E.A. Seftor, and R.J. Petrovan Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry Cancer Res 63 2003 5381 5389
75. R. Montesano, G. Schaller, and L. Orci Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors Cell 66 1991 697 711
76. G. Bergers, S. Song, N. Meyer-Morse, E. Bergsland, and D. Hanahan Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors J Clin Invest 111 2003 1287 1295
77. R. Erber, A. Thurnher, and A.D. Katsen Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms FASEB J 18 2004 338 340
78. L. Bello, G. Carrabba, and C. Giussani Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo Cancer Res 61 2001 7501 7506
79. B. Bussolati, I. Deambrosis, S. Russo, M.C. Deregibus, and G. Camussi Altered angiogenesis and survival in human tumor-derived endothelial cells FASEB J 17 2003 1159 1161
80. M.V. Blagosklonny Antiangiogenic therapy and tumor progression Cancer Cell 5 2004 13 17
81. P. Alessi, C. Ebbinghaus, and D. Neri Molecular targeting of angiogenesis Biochim Biophys Acta 1654 2004 39 49
82. X. Lu, F. le Noble, and L. Yuan The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system Nature 432 2004 179 189
83. C. Cursiefen, L. Chen, and L.P. Borges VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophages recruitment J Clin Invest 113 2004 1040 1050
84. N. Ferrara Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 2004 581 611
85. B. Blouw, H. Song, and T. Tihan The hypoxic response of tumors is dependent on their microenvronment Cancer Cell 4 2003 133 146